↑ Kohler, S. (2018). Precision medicine–moving away from one-size-fits-all. Quest, 14(3), 12-15.
↑ Costa, B., Estrada, M. F., Mendes, R. V., & Fior, R. (2020). Zebrafish avatars towards personalized medicine—A comparative review between avatar models. Cells, 9(2), 293.
↑ Tibaldi, J.M. Evolution of Insulin Development: Focus on Key Parameters. Adv Therapy 29, 590–619 (2012). https://doi.org/10.1007/s12325-012-0034-8
↑ Collins FS, McKusick VA. Implications of the Human Genome Project for Medical Science. JAMA. 2001;285(5):540–544. doi:10.1001/jama.285.5.540
↑ Pérez-Herrero, E., & Fernández-Medarde, A. (2015). Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy. European journal of pharmaceutics and biopharmaceutics, 93, 52-79.
↑ Russo, A., Franchina, T., Ricciardi, G. R. R., Picone, A., Ferraro, G., Zanghì, M., ... & Adamo, V. (2015). A decade of EGFR inhibition in EGFR-mutated non small cell lung cancer (NSCLC): Old successes and future perspectives. Oncotarget, 6(29), 26814.
